111 (NASDAQ:YI – Get Free Report) announced its earnings results on Thursday. The company reported ($0.20) EPS for the quarter, Zacks reports. The firm had revenue of $486.35 million during the quarter.
111 Stock Down 2.0%
YI opened at $7.75 on Friday. The business has a fifty day moving average of $7.99 and a 200 day moving average of $7.57. The stock has a market cap of $66.97 million, a P/E ratio of -12.11 and a beta of 0.47. 111 has a 52-week low of $4.15 and a 52-week high of $12.90.
Wall Street Analysts Forecast Growth
Separately, Weiss Ratings reiterated a “sell (e+)” rating on shares of 111 in a report on Wednesday, June 11th.
111 Company Profile
111, Inc engages in the provision of pharmaceutical products and medical services through online retail pharmacy and indirectly through offline pharmacy network. It operates through the B2C and B2B segments. The B2C segment engages in the sale of pharmaceutical and other health and wellness products directly to consumers through 1 Drugstore and its offline pharmacies.
Read More
- Five stocks we like better than 111
- Are These Liquid Natural Gas Stocks Ready For An Upside Bounce?
- These 3 Consumer Staple Giants Are Oversold and Set to Skyrocket
- How to buy stock: A step-by-step guide for beginnersÂ
- MarketBeat Week in Review – 06/16 – 06/20
- Best Energy Stocks – Energy Stocks to Buy Now
- New All-Time Highs Coming for Broadcom? Wall Street Says Yes
Receive News & Ratings for 111 Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for 111 and related companies with MarketBeat.com's FREE daily email newsletter.
